Get the app
NSEHealthcare

Poly Medicure Limited (POLYMED)

NSE · Healthcare · Medical Instruments & Supplies

₹1,712.70+0.48%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹525 cr
Revenue YoY
+30.3%
Net profit
₹86 cr
Profit YoY
-7.6%
EPS
₹8.48
EPS estimate
₹7.08
Net margin
16.4%

EPS came in at 8.48 against a street estimate of 7.08 — a beat of 19.8%.

Key statistics

Market cap
₹17,622 cr
P/E
55.9
Forward P/E
0.0
P/B
5.70
Book value
₹306.44
EPS (TTM)
₹31.11
52-week high
₹2,103.49
52-week low
₹1,179.58
50-day MA
₹1,718.12
200-day MA
₹1,566.92
Beta
0.01

Analyst view

with an average price target of ₹1,824.83.

Shareholding

Promoters
64.63%
Institutions
17.99%

Recent filings & reports

DocumentDate
Annual report FY20262026-08-14
Q1 FY27 earnings call
POLY MEDICURE LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Stand-alone revenue Q1 FY27: INR 431 crores, up 12.3% YoY - Domestic: INR 146 crores, u
2026-08-14
Investor presentation · Q1 FY27
POLY MEDICURE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY27 Consolidated Revenue: Rs 525.4 Cr (30.3% YoY growth); Standalone Revenue: Rs 431
2026-08-07
Quarterly results · Q1 FY27
POLY MEDICURE LIMITED - INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY2027 Standalone Revenue from Operations: Rs 43,109.95 lacs (down 2.7% YoY from Rs 3
2026-08-07
Q4 FY26 earnings call
POLY MEDICURE LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Full year FY26 standalone revenue: INR 1,662 crores, up 4% YoY • Full year FY26 consolida
2026-05-29
Quarterly results · Q4 FY26
POLY MEDICURE LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue from Operations (FY 2025-26 Standalone): ₹4,69,565.18 lacs
2026-05-25
Investor presentation · Q4 FY26
POLY MEDICURE LIMITED – INVESTOR SUMMARY Q4 & FY26 RESULTS --- HEADLINE NUMBERS • FY26 Standalone Revenue: Rs 1,662.5 Cr (+3.8% YoY); Q4 FY26: Rs 4
2026-05-25
Investor presentation2026-05-25

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹3.50 / share
ex-date Aug 28, 2026 · record Aug 29, 2026
2026-08-28
Dividend₹3.50 / share
ex-date Sep 18, 2025
2025-09-18

Deals & corporate news

AnnouncementDate
Acquisition of subsidiary company completed
Poly Medicure Limited, a medical device manufacturer, has announced the acquisition of a subsidiary company as per regulatory disclosure requirements under SEBI guidelines. Key Details: - T
2026-04-30
Completion of acquisition of Medistream SA by subsidiary
Poly Medicure Limited has completed its acquisition of Medistream SA, a Swiss corporation, through its wholly-owned subsidiary Poly Medicure B.V. based in Amsterdam, Netherlands. Key Points
2025-11-06
Acquisition of Citieffe Group completed
Poly Medicure Limited announced the acquisition of Citieffe Group on September 24, 2025. Citieffe Group is a European medical device manufacturer, making this a strategic expansion into inte
2025-09-24
Investor presentation on acquisition of Citieffee Group
Poly Medicure Limited has informed the Exchange about the Investor's Presentation on Acquisition of "Citieffee Group".
2025-09-24
Share Purchase Agreement for acquisition of Citieffe Group
Citieffe Group Acquisition Announcement What Happened: The company's Board of Directors met on September 24, 2025, and made updates regarding a Share Purchase Agreement for acquiring Citief
2025-09-24

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Poly Medicure Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.